4//SEC Filing
Shealy Jeffrey B. 4
Accession 0001493152-25-019755
CIK 0001938569other
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 4:32 PM ET
Size
8.0 KB
Accession
0001493152-25-019755
Insider Transaction Report
Form 4
Shealy Jeffrey B.
DirectorPresident and CEO10% Owner
Transactions
- Sale
Warrants
2025-09-29$1.20/sh+833,333$1,000,000→ 4,666,666 totalExercise: $1.50From: 2025-09-29→ Common Stock (833,333 underlying) - Other
Common Stock
2025-09-29+3,833,333→ 4,666,666 total
Footnotes (1)
- [F1]Per the terms of an Agreement and Plan of Merger, dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., "Pre-Merger Palomino"). Mr. Shealy, as a shareholder of Pre-Merger Palomino, received 3,000,000 shares of common stock, par value $0.0001 per share, of Issuer ("Common Stock") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Shealy converted his SAFEs into 833,333 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement).
Documents
Issuer
Palomino Laboratories Inc.
CIK 0001938569
Entity typeother
Related Parties
1- filerCIK 0001700683
Filing Metadata
- Form type
- 4
- Filed
- Oct 26, 8:00 PM ET
- Accepted
- Oct 27, 4:32 PM ET
- Size
- 8.0 KB